General description | pg & fig/table | ||
Title of the study | |||
Authors | |||
Year | |||
ID o DOI | |||
Objective | |||
Protocol and registration | |||
Population and study environment | pg & fig/table | ||
Description of the Population or animal model (species) | |||
Environment (includes location and social context) (human study) | |||
Total population at the beginning of the study Number of clusters (if applicable - Number and type of people per cluster) | |||
Age | |||
Sex | |||
Race / ethnicity | |||
Severity of the disease / co-morbidities | |||
Measurements by subgroup | |||
Methods | pg & fig/table | ||
Study design | |||
Analysis unit (individual, cluster / groups) | |||
Start / end Date | |||
Total duration of the study | |||
Exclusion criteria | |||
Recruitment method (human) | |||
Calculation of sample size | |||
Approval of the ethics committee | |||
Risk assessment of bias for animal and human studies (clinical trials) | pg & fig/table | ||
Domain | Type of risk | Supports | |
Low - High - “Unclear” | |||
Random sequence generation (Animal or human) | |||
Sequence concealment (Animal or human) | |||
Blinding of participants and staff (human) | |||
Blinding of outcome assessor (Animal or human) | |||
Incomplete outcome data (Animal or human) | |||
Selective outcome reporting (Animal or human) | |||
Baseline characteristics between groups (Animal or human) | |||
Random Housing (Animal) | |||
Random outcome assessment (animal) | |||
Blinding of the caregiver or researcher (Animal) | |||
Intervention characteristics | |||
Definition | |||
Administration method | |||
Intervention duration | |||
Comparator group characteristics | |||
Definition | |||
Administration method | |||
Intervention duration | |||
Outcome | pg & fig/table | ||
Outcome name | |||
Definition | |||
How the measurement was applied (interview, email, telephone ...) | |||
Losses (%) | |||
Imputation of lost data | |||
Results (most important)%, mean, standard deviation. | |||
Statistical method used | |||
Other information | pg & fig/table | ||
Conclusions | |||
Financing sources | |||
Note: |